Hologic Inc (HOLX) 38.98 $HOLX National Comprehensive

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hologic Inc (HOLX) 38.98 $HOLX

National Comprehensive Cancer Network (NCCN) Includes Breast Tomosynthesis in Breast Cancer Screening and Diagnosis Practice Guidelines
PR Newswire - Mon Aug 01, 7:01AM CDT
Hologic Inc. (Nasdaq: HOLX) announced today that new guidelines published by the National Comprehensive Cancer Network (NCCN) recommend that physicians consider breast tomosynthesis exams as an option for their patients' annual breast cancer screening.1
HOLX: 38.98 (+0.49)

Upgrade Alert for Hologic (HOLX)
Comtex SmarTrend(R) - Fri Jul 29, 3:08AM CDT
Hologic (NASDAQ:HOLX) was upgraded from Hold to Buy at Evercore ISI today. The stock closed yesterday at $38.27 on volume of 4.5 million shares, below average daily volume of 5.5 million. Hologic, Inc. develops, manufactures, and markets x-ray systems. The Company makes x-ray bone densitometers that measure the precise bone density for use in the diagnosing of metabolic bone diseases such as osteoporosis.
HOLX: 38.98 (+0.49)

Hologic Rises 2.45% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jul 28, 12:54PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.62 to a high of $38.71. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $37.29 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.98 (+0.49)

After Yesterday's Rally of 2.45% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Jul 28, 12:53PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.62 to a high of $38.71. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $37.29 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.98 (+0.49)

Hologic (HOLX) Beats on Q3 Earnings, Sales; '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:29AM CDT
Hologic (HOLX) ended third-quarter fiscal 2016 on a promising note, with both its top and bottom line comfortably exceeding the Zacks Consensus Estimate.
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), HOLX: 38.98 (+0.49)

CVS Health (CVS) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:43PM CDT
CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
ZBH: 131.06 (-0.08), CVS: 93.49 (+0.77), BMY: 76.19 (+1.38), HOLX: 38.98 (+0.49)

Hologic Announces Financial Results for Third Quarter of Fiscal 2016
PR Newswire - Wed Jul 27, 3:01PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal third quarter ended June 25, 2016. GAAP diluted earnings per share (EPS) of $0.30 increased 200% compared to the prior year period, and non-GAAP diluted EPS of $0.51 increased 18.6%. Revenue of $717.4 million increased 3.4%, or 3.6% in constant currency terms.
HOLX: 38.98 (+0.49)

Research and Markets - Global Diagnostic Imaging Market, 2022 - Key Players are Analogic, GE, Philips, Siemens, Toshiba Medical, Hitachi Medical, Carestream, Hologic, Samsung Medison & Shimadzu
PR Newswire Europe - Wed Jul 27, 8:11AM CDT
DUBLIN, July 27, 2016 /PRNewswire/ --
HOLX: 38.98 (+0.49)

Henry Schein (HSIC) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 6:56AM CDT
Henry Schein's (HSIC) earnings surpassed the Zacks Consensus Estimate in 3 of the past 4 quarters, with an average beat of 2.03%.
ZBH: 131.06 (-0.08), BMY: 76.19 (+1.38), HSIC: 180.14 (-0.84), HOLX: 38.98 (+0.49)

Look at Jul 27 Medical Instrument Earnings: HOLX, VAR & More
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 6:51AM CDT
There is some definite good news for investors keen on the Medical sector.
RTIX: 3.10 (-0.15), VAR: 94.84 (+0.10), NVDQ: 10.92 (+0.26), HOLX: 38.98 (+0.49)

Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:31AM CDT
Hologic (HOLX) has a Zacks Rank #2 (Buy) which along with a 0.00 % ESP makes surprise prediction difficult.
AGN: 254.86 (+1.91), LH: 139.63 (+0.07), BMY: 76.19 (+1.38), HOLX: 38.98 (+0.49)

MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 119.50 (+1.53), LDRH: 36.98 (-0.02), MDT: 88.06 (+0.43), PAHC: 20.83 (+0.20), MLAB: 114.10 (-1.53), NUVA: 63.29 (+1.09), BSX: 24.43 (+0.15), BABY: 39.18 (-0.15), SNN: 33.18 (-0.11), JNJ: 125.40 (+0.17), DXCM: 92.65 (+0.42), GWPH: 96.11 (+1.79), RMD: 69.85 (+0.97), WOOF: 70.40 (-0.94), ABT: 45.29 (+0.54), VIVO: 19.55 (+0.19), MASI: 52.93 (-0.04), TMO: 159.56 (+0.72), CYH: 12.58 (-0.19), HTWR: 57.96 (+0.02), FEIC: 106.45 (+0.03), ISRG: 693.87 (-1.89), CFMS: 6.92 (-0.05), STE: 71.41 (+0.46), STJ: 83.73 (+0.69), XRAY: 64.23 (+0.19), HOLX: 38.98 (+0.49)

Hologic Set to Possibly Pullback After Yesterday's Rally of 1.84%
Comtex SmarTrend(R) - Thu Jul 07, 1:13PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $34.61 to a high of $35.79. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $35.00 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.98 (+0.49)

Watch for Hologic to Potentially Pullback After Gaining 1.84% Yesterday
Comtex SmarTrend(R) - Thu Jul 07, 1:11PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $34.61 to a high of $35.79. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $35.00 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.98 (+0.49)

MEDNAX Stock Up On Accretive Acquisitions & Collaborations
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:19AM CDT
MEDNAX Inc. (MD) shares has increased 13.3% in the last three months driven by a plethora of accretive acquisitions.
IBM: 161.45 (+0.83), MD: 68.99 (+0.08), HOLX: 38.98 (+0.49), MCO: 105.27 (-0.74)

Hologic Set to Possibly Pullback After Yesterday's Rally of 3.40%
Comtex SmarTrend(R) - Thu Jun 23, 12:47PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $34.17 to a high of $35.33. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $34.77 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.98 (+0.49)

Hologic: FDA Okays Procleix Zika Virus Test under IND Study
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:51AM CDT
Hologic's (HOLX) Procleix Zika Virus Test was approved under FDA???s Investigational New Drug (IND) study protocol to detect the presence of Zika virus in donated blood.
ICUI: 117.07 (+0.31), BAX: 48.50 (+0.48), LMAT: 17.89 (+0.69), HOLX: 38.98 (+0.49)

Hologic's Zika Virus Test Gets FDA Nod for Emergency Use
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:58AM CDT
Hologic (HOLX) will run the Aptima Zika virus test on its market leading Panther platform, which substantially reduces hands-on time for laboratories and the potential for manual errors.
ICUI: 117.07 (+0.31), BAX: 48.50 (+0.48), LMAT: 17.89 (+0.69), HOLX: 38.98 (+0.49)

FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol
PR Newswire - Mon Jun 20, 7:00AM CDT
Hologic, Inc. (NASDAQ: HOLX) and Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) - market-leading partners committed to blood safety - announced today that the U.S. Food and Drug Administration (FDA) has approved use of the Procleix Zika virus blood screening assay on the Procleix Panther system under the agency's Investigational New Drug (IND) study protocol.
GRFS: 16.76 (-0.18), HOLX: 38.98 (+0.49)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 164

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 129

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 142

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Ridgeline’s Dome Roof Award Signals Durable Craft Demand

Updated Category News Views 69

A faceted dome in the Alabama woods is about as far from a cookie-cutter reroof as it gets. Ridgeline Roofing & Restoration’s 2026 Excellence Award from Brava Roof Tile matters because the job in Pell City demanded the sort of painstaking field execution that separates a capable contractor from a crew merely moving shingles fast. Geometry Is Where Easy Claims Go to Die...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 120

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 158

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Norfolk Southern's 200-Year Campaign Meets a Hard Market

Updated Category News Views 61

Two centuries of railroad history can stir the blood, but it does not move a single carload by itself. Norfolk Southern has opened its 200-year railroading celebration with the GeneratioNS campaign, a three-locomotive NS 200 commemorative series, and plans for public events across its network. For a railroad with deep roots and very modern operational pressures, this is...

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 174

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 125

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
ArchiPro Enters U.S. Design Market With Curated Bet

Updated Category News Views 56

Blue-chip furniture and glossy project photos are not a moat by themselves, no matter how hard a platform tries to make them look like one. But ArchiPro’s full U.S. launch deserves a closer look because it arrives with something many would-be marketplace operators lack: more than a decade of operating history in New Zealand and Australia. A Three-Sided Machine Meets...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of SOC-as-a-Service to $14.66 Billion

Updated Category News Views 198

Understanding SOC-as-a-Service Market Growth The global SOC-as-a-Service market is projected to witness substantial growth, anticipated to reach a value of USD 14.66 billion by 2030. This growth surge represents a remarkable increase from USD 7.37 billion and reflects a compound annual growth rate (CAGR) of 12.2% during the period from 2024 to 2030. The surge in demand...

Continue Reading
Revolutionary Anti-Aging Hair Solution Launches for Men

Updated Category News Views 308

Just For Men® Launches Gray Reverse™ Hair Serum In an exciting development for men's grooming, Just For Men® has unveiled its latest innovation, the Gray Reverse™ Hair Serum. This groundbreaking product is designed to help men fight against the signs of aging, specifically graying hair, and play a key role in maintaining their natural appearance. Understanding the...

Continue Reading
Legal Guidance for Lantheus Holdings Investors Amid Class Action

Updated Category News Views 242

Introduction to Lantheus Holdings Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a significant player in the medical technology sector, specializing in diagnostic imaging and therapeutic agents. The company focuses on enhancing diagnosis, treatment, and monitoring of various health conditions. As it gears up for a challenging period marked by considerable scrutiny,...

Continue Reading
OpenAI Explores Development of Innovative Web Browser

Updated Category News Views 167

OpenAI Explores Development of Innovative Web Browser OpenAI, the company behind the popular AI chatbot ChatGPT, is taking strategic steps that could reshape the landscape of web browsing. Recently, it has been reported that OpenAI is contemplating the creation of a new web browser that could work harmoniously with its advanced chatbot technologies. This potential...

Continue Reading
Mercedes-Benz Faces Challenges with New FY24 Financial Guidance

Updated Category News Views 355

Mercedes-Benz Updates Fiscal Year 2024 Projections Recently, the Mercedes-Benz Group adjusted its financial outlook for the fiscal year 2024. Despite this reevaluation, Morgan Stanley has chosen to keep its Overweight rating on Mercedes-Benz (OTC: MBGAF) along with a solid price target of EUR 82.00. This decision comes even as the company revised its financial...

Continue Reading